With the advent and optimization of nuclear scintigraphy protocols using bone-avid radiotracers, cardiac amyloidosis caused by transthyretin protein (ATTR) can now be diagnosed noninvasively without a costly tissue biopsy. The radiotracer 99mTc-pyrophosphate (99mTc-PYP) binds to deposited ATTR amyloid fibrils in the myocardium and can be visualized using planar and SPECT imaging. Amyloidosis Patient Registry #Amyloidosis
March 05, 2020
Amyloidosis Patient Registry Hits 300 Participants and Now Open to Entire Community
March 5, 2020 — More than 300 patients have joined the Amyloidosis Patient Registry and it is now available to the…
Read More
TeraRecon will accelerate innovation in its advanced visualization and AI platforms for image-related decision support to clinical specialists
March 04, 2020
SymphonyAI Group Acquires TeraRecon
March 4, 2020 — SymphonyAI Group, an operating group of leading business-to-business AI companies, today announced the…
Read More
Fears and travel restrictions due to the coronavirus has caused two European medical conferences to postpone their meetings so far in 2020. #COVID19 #Coronavirus #2019nCoV #Wuhanvirus
Dave Fornell, Editor
March 03, 2020
Coronavirus Fears Cancel European Cardiology and Radiology Conferences
March 3, 2020 — Two sizable European medical conferences in cardiology and radiology were canceled today as fears…
Read More
Coronavirus (COVID-19) and the FDA clearance of the Micra AV, the world’s smallest pacemaker with atrioventricular (AV) synchrony, topped the news analytics in February 2020 on DAIC magazine. COVID-19 virus image courtesy of CDC.
Dave Fornell, Editor
March 02, 2020
Most Popular Cardiology Technology Content in February 2020
March 2, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC)…
Read More
AI vendor Infravision's InferRead CT Pneumonia software uses artificial intelligence-assisted diagnosis tp improve the overall efficiency of the radiology department. It is being delayed in China as a high sensitivity detection aid for novel coronavirus pneumonia (COVID-19). #COVID-19 #COVID19 #Coronavirus #2019-nCoV
February 28, 2020
Emerging Technologies Proving Value in Chinese Coronavirus Fight
February 28, 2020 — New healthcare technologies are being implemented in the fight against the novel coronavirus (COVID…
Read More
Aria CV Pulmonary Hypertension System_Aria CV PH System
February 27, 2020
Aria CV Pulmonary Hypertension Acquires $31 Million for Feasibility Study
February 27, 2020 — Aria CV Inc. completed a $31 million Series B round of financing to fund its first clinical study…
Read More
The LivaNova Heater-Cooler System 3T helps open heart surgery patients, but can pose an infection risk if not properly cared for.
February 27, 2020
How to Reduce the Risk of Cardiac Surgery Infection When Using LivaNova Heater-Cooler System
February 27, 2020 — The U.S. Food and Drug Administration (FDA) sent a safety communication this week to healthcare to…
Read More
An illustration of the novel coronavirus (COVID-19) from the CDC. #coronavirus #COVID19 #COVID-2019 #2019nCoV
Dave Fornell, Editor
February 25, 2020
CDC Hopes to Buy Time Before Likely Coronavirus Spread in U.S.
The Centers for Disease Control and Prevention (CDC) said it is working to contain the spread of the novel coronavirus…
Read More
A 3-D reconstruction of a cardiac CT scan showing an implanted Medtronic CoreValve TAVR device. Imagine courtesy of TeraRecon. #TAVR #TAVI
Dave Fornell, Editor
February 24, 2020
TAVR Expected to See Rapid Growth in Next 5 years
In August 2019, the U.S. Food and Drug Administration (FDA) expanded the indication for the use of transcatheter aortic…
Read More
NC Trek RX Coronary Dilatation Catheter is part of an FDA Class I recall because it may not defalte.
February 24, 2020
Abbott Recalls Two Coronary Balloon Catheters That May Not Deflate
February 24, 2020 — Abbott has voluntarily recalled specific lots of two types of its coronary angioplasty catheters —…
Read More
Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the 2020 Cardiovascular Research Technologies (CRT) Congress. The three-year follow-up data demonstrates consistently lower clinical event rates and improvement in patient outcomes, reinforcing the differentiation of the Orsiro coronary drug-eluting stent (DES), which is the first DES to outperform Xience.
February 24, 2020
Biotronik's Orsiro Stent Continues Excellent Results After Three Years
February 24, 2020 — Biotronik announced three-year data from the BIOFLOW-V Trial, which was presented yesterday at the…
Read More
The U.S. Food and Drug Administration (FDA) approved Esperion's bempedoic acid (Nexletor) tablet, an oral, once-daily, non-statin low-density lipoprotein cholesterol (LDL-C) lowering medicine. The drug is indicated as an adjunct to diet and maximally tolerated statin therapy for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH) or established atherosclerotic cardiovascular disease (ASCVD) who require additional lowering of LDL-C. 
February 24, 2020
FDA Clears Bempedoic Acid Non-statin LDL-cholesterol Lowering Drug
February 24, 2020 — The U.S. Food and Drug Administration (FDA) approved Esperion's bempedoic acid (Nexletor) tablet,…
Read More
Some of the new devices technologies to treat heart failure that are either in clinical trials or were recently cleared by the U.S. FDA. #heartfailure
Dave Fornell, Editor
February 21, 2020
New Heart Failure Devices and Drugs to Treat Heart Failure
There are several new tools being added to the clinical armamentarium in the fight against heart failure (HF). These…
Read More
Tufts Medical Center created a heart failure team approach to care for its patients. The program includes an interventional heart failure fellowship program, where interventional cardiologists learn more advanced care, as show here with an ECMO procedure being performed in a cath lab at Tufts. The interventional cardiologists learn how to better care for heart failure patients and interface with surgeons, intensivists and others on the HF care team. The operator is Nevin Kapur. Photo by Dave Fornell.
Dave Fornell, Editor
February 20, 2020
3 New Approaches to Reduce Heart Failure Readmissions
There is no, single magic bullet in heart failure (HF) to easily reduce readmission rates or easily reverse this…
Read More
A 3-D rendering created from the chest CT scan of a 41-year-old coronavirus patient in China showing ground-glass opacities in several areas of the lungs from the coronavirus pneumonia. This was from one of the first medical imaging studies published on COVID-19 in the journal Radiology. #coronavirus #COVID2019 #COVID19 #2019nCoV #SARS‐CoV‐2
Dave Fornell, Editor
February 20, 2020
The Cardiac Implications of Novel Coronavirus
(Article updated May 27, 2020) February 20, 2020 — The American College of Cardiology (ACC) released a clinical…
Read More
Synaptive Medical, a leader in robotic surgical visualization, announced today the company has secured approval from Health Canada for Evry, the company’s superconducting, head magnetic resonance imaging (MRI) system
February 20, 2020
Synaptive Medical Secures Health Canada Approval for Evry
February 20, 2020 — Synaptive Medical, a leader in robotic surgical visualization, announced today the company has…
Read More
Siemens Healthineers has introduced CentriCare, a new, patient-centric service contract portfolio
February 20, 2020
Siemens Healthineers Debuts CentriCare Service Portfolio
February 20, 2020 — Siemens Healthineers has introduced CentriCare — a new, patient-centric service contract portfolio…
Read More
Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 
February 19, 2020
Moving Beyond Holter ECG: The Rise in Next Generation Technology 
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “…
Read More
Cardiac MR, also called cardiac MRI or heart MRI, can offer data above and beyond anatomical imaging.
Dave Fornell, Editor
February 19, 2020
Cardiac MRI Becoming More Widely Available Thanks to AI and Reduced Exam Times
Magnetic resonance imaging (MRI) has been described for the past few decades as a futuristic imaging technology that…
Read More
Rupa Sanghani, M.D., FASNC, director of Rush's nuclear cardiology and stress laboratory, explaining to ASNC 2019 attendees how Rush implemented its program during a tour of its PET-CT suite.
Dave Fornell, Editor
February 19, 2020
How to Start a Cardiac PET-CT Imaging Program
As hospital imaging departments look to replace aging nuclear scanners with updated technology, many are asking if…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now